References
- Harvey A M, Shulman L E, Tumulty P A, Conley C L, Schoenrich E H. Systemic lupus erythematosus: Review of the literature and clinical analysis of 138 casts. Medicine (Baltimore) 1951; 33: 291–437
- Michael S R, Vural I L, Bassen F A, Schafer L. The hematologic aspects of disseminated (systemic) lupus erythematosus. Blood 1951; 6: 1059–72
- Budman D R, Steinberg A D. Hematologic aspects of systemic lupus erythematosus. Ann Intern Med 1977; 86: 220–9
- Hasselbalch H. Idiopathic myelofibrosis - an update with particular reference to clinical aspects and prognosis. Int J Clin Lab Res 1993; 23: 121–38
- Burkhardt R. The hone marrow in systemic lupus erythematosus. Semin Hematol 1965; 2: 29–46
- Paquette R L, Meshkinpour A, Rosen P J. Autoimmune myelofibrosis. A steroid-responsive cause of bone marrow fibrosis associated with systemic lupus erythematosus. Medicine 1994; 73: 145–52
- Gordon B R, Coleman M, Kohen P. Day NK Immunologic abnormalities in myelofibrosis with activation of the complement system. Blood; 1981; 58: 904–10
- Rondeau E, Solal-Celigny P, Dhermy D, Vroclans M, Brousse N, Bernard J E, Boivin P. Immune disorders in agnogenic myeloid metaplasia: Relations to myelofibrosis. Br J Haematol 1993; 53: 467–75
- Liu H, Ozaki K, Matsuzaki Y, Abe M, Kosaka M, Saito S. Suppression of haematopoiesis by lgG autoantibodies from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1995; 100: 480–5
- Feng C S, Ng M H, Szeto R S, Li E K. Bone marrow findings in lupus patients with pancytopenia. Pathology 1991; 23: 5–7
- Dalai B I, Keown P A, Paraskevas F, Williams G, Johnston J B. Cytokine profile in acute myclofibrosis associated with aggressive large granular lymphoeyte leukaemia. Am J Hematol; 1995; 49: 349–52
- Le Rousse-Kerdiles M C, Chevillard S, Charpentier A, Romquin N, Clay D, Smadja-Jerk F, Praloran V, Dupriez B, Demory J L, Jasmin C, Martyre M C. Differential expression of transforming growth factor-beta. basic fibroblast growth factor. and their receptors in CD34+ hematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasia. Blood 1996; 88: 4534–16
- Lau K S, White J C. Myclosclerosis associated with systemic lupus erythematosus in patients in West Malaysia. J Clin Pathol 1969; 22: 433–8
- Daly H M, Scott G L. Myelofibrosis as a cause of pancytopenia in systemic lupus erythematosus. J Clin Pathol 1993; 36: 1219–22
- Nanji A, Jetha A. N. Myelofibrosis as a cause of pancytopenia iii systemic lupus erythematosus. J Clin Pathol 1984; 37: 714
- Kaelin W G, Jr, Spivak J L. Systemic lupus erythematosus and myelofibrosis. Am J Med 1986; 81: 935–8
- el Mouzan M I, Ahmad M A, al Fadel Saleh M, al Sohaibani M O., al Gindan Y M. Myelofibrosis and pancytopenia in systemic lupus erythematosus. Acts Haematol; 1988; 80: 219–21
- Matsouka C, Liouris J, Andrianakos A, Papademetriou C, Karvountzis G. Systemic lupus erythematosus and myelofibrosis. Clin Rheumatol 1989; 8: 402–7
- Bistue R, Gallo de Sprazzato M E, Seognamillo C D, Porretta de Croceri L, Estevez M M, Guerra D. Coexistence of myelofibrosis and collagen diseases. Medicina 1990; 50: 218–50
- Inoue Y, Matsubara A, Okuya S, Okafuji K, Kaku K, Kaneko T. Myelofibrosis and systemic lupus erythematosus: reversal of fibrosis with high-dose corticosteroid therapy. Acta Haematol 1912; 88: 32–6
- Foley-Nolan D, Martin M F, Rowbotham D, McVerry A, Gooi H C. Systemic lupus erythematosus presenting with myelofibrosis. J Rheumatol 1992; 19: 1303–4
- Borba E F, Pereira R M, Velloso E D, Pereira I A, Goncalves C K, Yoshinari N. Neutropenia associated with myelofibrosis in systemic lupus erythematosus. Acta Haematol 1993; 89: 82–5
- Fukuya H, Hirose W, Masuda T, Kawai T, Watanabe K, Kawagoe M. A case of systemic lupus erythematosus presenting with myelofibrosis as a cause of pancytopenia. Ryumachi 1994; 34: 773–8
- Ramakrishna R, Kyle P W, Day P J, Manoharan A. Evans' syndrome. myelofibrosis and systemic lupus erythematosus: role of procollagens in myelofibrosis. Pathology 1995; 27: 255–9
- Agarwal B R, Bhalla K, Dalvi R, Currimbhoy Z E, Mehta K P. Myelofibrosis secondary to SLE and its reversal on steroid therapy. Indian Pediatr 1995; 32: 1207–10
- Aharon A., Levy Y., Bar-Dayan Y., Afek A., Zandman-Goddard G., Skurnik Y., Fabrrizzi F, Shoenfeld Y. Successful treatment of early secondary myelofibrosis in SLE with IVIG. Lupus 1997; 6: 408–11
- Konstantopoulos K, Terpos E, Prinolakis H, Kanta A, Variami E, Kanellopoulou G, Vaiopoulos G, Floros A, Androulaki A, Meletis J. Systemic lupus erythematosus presenting as myelofibrosis. Haematologia 1998; 3: 153–4
- Schur P H, Marcus-Bagley D, Awdeh Z, Yunis E J, Alper C A. The effect of ethnicity tin major histocompatibility complex complement allotypes and extended haplotypes in patients with systemic lupus erythematosus. Arthritis Rheum; 1990; 33: 985–92
- Aharon A, Levy Y, Bar-Dayan Y, Afek A, Zandman-Goddard G, Skurnik Y, Fabrrizzi F, Shoenfeld Y. Successful treatment of early secondary myelofibrosis in SLE with IVIG. Lupus 1997; 6: 108–11